|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-2-9
|
|
pubmed:abstractText |
MMP-2 expression in ovarian cancer cells has been correlated with poor prognosis. This study attempts to assess the prognostic importance of stromal MMP-2 in patients with ovarian endometrioid and serous adenocarcinoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0090-8258
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
92
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
559-67
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14766248-Carcinoma, Endometrioid,
pubmed-meshheading:14766248-Cystadenocarcinoma, Serous,
pubmed-meshheading:14766248-Disease Progression,
pubmed-meshheading:14766248-Female,
pubmed-meshheading:14766248-Humans,
pubmed-meshheading:14766248-Immunohistochemistry,
pubmed-meshheading:14766248-Matrix Metalloproteinase 2,
pubmed-meshheading:14766248-Matrix Metalloproteinases, Membrane-Associated,
pubmed-meshheading:14766248-Metalloendopeptidases,
pubmed-meshheading:14766248-Middle Aged,
pubmed-meshheading:14766248-Neoplasm Staging,
pubmed-meshheading:14766248-Ovarian Neoplasms,
pubmed-meshheading:14766248-Prognosis,
pubmed-meshheading:14766248-Stromal Cells,
pubmed-meshheading:14766248-Survival Rate,
pubmed-meshheading:14766248-Tissue Inhibitor of Metalloproteinase-2,
pubmed-meshheading:14766248-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. ctl@ha.mc.ntu.edu.tw
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
